The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Osteoarthritis Pain.
Completed · Phase 3
Conditions studied: Osteoarthritis
In brief
The objective of this study is to demonstrate the effectiveness and tolerability of the buprenorphine transdermal system (5, 10, and 20 mg) in comparison to placebo transdermal system and immediate release oxycodone/acetaminophen in subjects with osteoarthritis pain inadequately treated with non-opioid analgesics. The double-blind treatment intervention duration is 60 days.
Key facts
- Study ID
- NCT00315848
- Run by
- Purdue Pharma LP
- People needed
- 225
- Starts
- 1996-11-01
- Expected to finish
- 1999-12-01
- Last updated by the study team
- 2006-05-03
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- unacceptable pain control despite currently taking a nonsteroidal anti-inflammatory drug considered at a therapeutic and/or tolerated dose or currently taking </=2 short-acting opioid doses per day.
- taking >/=3 opioid doses per day with or without acceptable pain control.
You may not qualify if…
- receiving opioids at an average daily dose of greater than 60 mg of oral morphine equivalents or subjects receiving more than 6 tablets per day of a short-acting opioid.
- scheduled to have surgery (including dental) involving the use of post- or preoperative analgesics or anesthetics during the study period.
- Other protocol-specific exclusion/inclusion criteria may apply.
Where it is running
- Rheumatology Associates of North Alabama — Huntsville, Alabama, United States
- Arizona Research and Education — Phoenix, Arizona, United States
- Phoenix Center for Clinical Research — Phoenix, Arizona, United States
- Western Integrated Pain Treatment Centers — Westminster, Colorado, United States
- Gainesville Clinical Research Center — Gainesville, Florida, United States
- Park Place Therapeutic Center — Plantation, Florida, United States
- MediSphere Medical Research Center, L.L.C. — Evansville, Indiana, United States
- Stratton VA Medical Center — Albany, New York, United States
- Metroplex Clinical Research Center — Dallas, Texas, United States
- Arthritis Diagnostic and Treatment Center — San Antonio, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.